Rating
Buy
Price target
$300
Previous
$280
Implied upside
+43%

UBS analyst Timothy Arcuri raised the price target on NVIDIA (NASDAQ: NVDA) to $300 (from $280) while maintaining a Buy rating.

“Results were very strong and guidance spot in-line w/our preview, but most importantly, NVDA is finally providing firmer guidance on C2027 that implies EPS >$16 even as gross margins face near-term headwinds from memory price inflation.

We like the choice to explicitly guide next year (as opposed to its prior backlog commentary) and we think demand still far exceeds this number so there is still room to walk this higher if supply and powered data center shell capacity allow.

To make the point about demand, we think NVDA is tracking to ship ~13GW this year (~7GW to hyperscalers and ~6GW to neoclouds) and NVDA’s new C2027 guidance (including ASP increases) implies ~19-20GW.

However, the emergence of SPCX (which UBS estimates is implying ~6GW added in C2027) would seem to put NVDA in a heavy allocation situation and leave little to no room for shipments to hyperscalers to grow at all.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.